Currently out of the existing stock ratings of Kemp Dolliver, 5 are a BUY (83.33%), 1 are a HOLD (16.67%).

Kemp Dolliver

Work Performance Price Targets & Ratings Chart

Analyst Kemp Dolliver works at BROOKLINE with a stock forecast success ratio of 8.33% fulfilled within 1.25 days on average.

Kemp Dolliver’s has documented 12 price targets and ratings displayed on 4 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on PNT, POINT Biopharma Global at 21-Dec-2023.

Wall Street Analyst Kemp Dolliver

Analyst best performing recommendations are on PNT (POINT BIOPHARMA GLOBAL).

Average potential price target upside

ECOR Electrocore LLC VRCA Verrica Pharmaceuticals PNT POINT Biopharma Global ONCT Oncternal Therapeutics

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

15

$8.91 (146.31%)

11

2 months 5 days ago

1/7 (14.29%)

$7.77 (107.47%)

318

Buy

1.25

$-5.56 (-81.64%)

1 years 2 months 14 days ago

0/1 (0%)

$-3.28 (-72.41%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Kemp Dolliver is most bullish on?

Potential upside of $0 has been obtained for PNT (POINT BIOPHARMA GLOBAL)

Which stock is Kemp Dolliver is most reserved on?

Potential downside of -$6.2 has been obtained for ONCT (ONCTERNAL THERAPEUTICS)

What Year was the first public recommendation made by Kemp Dolliver?

On 2021

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?